Johnson-Obaseki S - Search Results

1

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.

Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Corsten M, Johnson-Obaseki S, Eapen L, Odell M, Parker C, Wehrli B, Kwan K, Palma DA. Nichols AC, et al. Lancet Oncol. 2019 Oct;20(10):1349-1359. doi: 10.1016/S1470-2045(19)30410-3. Epub 2019 Aug 12. Lancet Oncol. 2019. PMID: 31416685 Clinical Trial.

2

Head and neck cancer in Canada: trends 1992 to 2007.

Johnson-Obaseki S, McDonald JT, Corsten M, Rourke R. Johnson-Obaseki S, et al. Otolaryngol Head Neck Surg. 2012 Jul;147(1):74-8. doi: 10.1177/0194599812437332. Epub 2012 Feb 10. Otolaryngol Head Neck Surg. 2012. PMID: 22328702

3

Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991-2006.

Guay B, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M. Guay B, et al. Thyroid. 2014 Mar;24(3):552-5. doi: 10.1089/thy.2013.0308. Epub 2013 Nov 14. Thyroid. 2014. PMID: 24003960

4

Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007.

Hwang E, Johnson-Obaseki S, McDonald JT, Connell C, Corsten M. Hwang E, et al. Oral Oncol. 2013 Nov;49(11):1072-6. doi: 10.1016/j.oraloncology.2013.08.002. Epub 2013 Sep 7. Oral Oncol. 2013. PMID: 24018186

5

The relationship between survival and socio-economic status for head and neck cancer in Canada.

McDonald JT, Johnson-Obaseki S, Hwang E, Connell C, Corsten M. McDonald JT, et al. J Otolaryngol Head Neck Surg. 2014 Jan 14;43(1):2. doi: 10.1186/1916-0216-43-2. J Otolaryngol Head Neck Surg. 2014. PMID: 24422754 Free PMC article.

6

Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review.

Kelly K, Johnson-Obaseki S, Lumingu J, Corsten M. Kelly K, et al. Oral Oncol. 2014 Aug;50(8):696-703. doi: 10.1016/j.oraloncology.2014.04.005. Epub 2014 Jun 7. Oral Oncol. 2014. PMID: 24917389 Review.

7

Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors.

Dayekh K, Johnson-Obaseki S, Corsten M, Villeneuve PJ, Sekhon HS, Weberpals JI, Dimitroulakos J. Dayekh K, et al. Mol Cancer Ther. 2014 Nov;13(11):2559-71. doi: 10.1158/1535-7163.MCT-13-1086. Epub 2014 Sep 4. Mol Cancer Ther. 2014. PMID: 25189541

8

Response to: "No evidence for improved TORS post-treatment feeding tube dependency rate relative to standard therapy in early stage oropharyngeal cancer".

Johnson-Obaseki S, Kelly K, Corsten M. Johnson-Obaseki S, et al. Oral Oncol. 2015 Sep;51(9):e68. doi: 10.1016/j.oraloncology.2015.06.001. Epub 2015 Jun 26. Oral Oncol. 2015. PMID: 26120092 No abstract available.

9

Incidence of differentiated thyroid cancer in Canada by City of residence.

Corsten MJ, Hearn M, McDonald JT, Johnson-Obaseki S. Corsten MJ, et al. J Otolaryngol Head Neck Surg. 2015 Sep 15;44(1):36. doi: 10.1186/s40463-015-0088-0. J Otolaryngol Head Neck Surg. 2015. PMID: 26374205 Free PMC article.

10

Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992-2006.

Johnson-Obaseki SE, Labajian V, Corsten MJ, McDonald JT. Johnson-Obaseki SE, et al. J Otolaryngol Head Neck Surg. 2015 Dec 2;44:53. doi: 10.1186/s40463-015-0107-1. J Otolaryngol Head Neck Surg. 2015. PMID: 26631308 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page